Modifier 25 Documentation for Same-Day E/M Visits

Modifier 25 Documentation for Same-Day E/M With Minor Procedures: The 2026 Clinical Playbook

Merry AI · Thoughtfully curated clinical briefs.

Clinically reviewed by Dr. Marcus Vance, MD (Medical Informatics Advisor) · Coding review by Kaif R. (Clinical Informatics Specialist) · Sources: CY 2026 CMS PFS, NCCI Policy Manual.

Modifier 25 is payable on the same day as a minor procedure only when the note documents a significant, separately identifiable E/M service. That service must go beyond the pre-procedure evaluation already paid inside the procedure's 0-day or 10-day global package. A different diagnosis is not required. Documented work that a payer can see is separate from the procedure is required.

This playbook gives outpatient specialty physicians in orthopedics, dermatology, rheumatology, podiatry, and pain medicine a documentation structure that holds up under MAC and commercial audits. It also covers 2021 MDM thresholds applied to procedure days, and the G2211 billing boundary that still trips up specialty practices in 2026.

Minor procedure payment already includes the decision to perform it

CMS defines minor procedures as services with a 0-day or 10-day global period. Under the Medicare Claims Processing Manual, Chapter 12, Section 30.6.6, and the NCCI Policy Manual, Chapter I, the global payment includes the routine evaluation before the procedure. That includes confirming the indication, examining the site, discussing risks, and obtaining consent.

The practical consequence is direct: if the only reason the patient was seen was to perform a planned procedure, you report the procedure alone. Common examples include:

• CPT 20610 (major joint arthrocentesis/injection): 0-day global.
• CPT 11102 (tangential skin biopsy): 0-day global.
• CPT 17000 (destruction of premalignant lesion): 10-day global.

Major procedures follow a different rule. These are services with a 90-day global period. The E/M visit at which the decision for surgery is made, on the day before or the day of surgery, takes modifier 57, not modifier 25. Applying modifier 25 to a 90-day global decision visit is a common, avoidable denial.

A different diagnosis is not required, but separate work is

CPT guidance explicitly states that the E/M service may be prompted by the same symptom or condition for which the procedure is provided. Auditors still look for diagnosis separation, though, because it is the fastest visual signal of distinct work. When the E/M and the procedure share a single ICD-10-CM code, the note must carry the full burden of proof.

New patient status alone does not justify a separate E/M. Section 30.6.6 states this directly. A new patient who arrives with a known diagnosis for a scheduled injection does not generate a billable 99203 simply because the encounter is the first.

Separate work typically looks like one of four patterns:

• Evaluating an undiagnosed new complaint: the workup is what leads to the procedure.
• Managing a chronic condition that worsened: the change goes beyond the procedure site.
• Addressing an additional, unrelated problem: for example, a second anatomic site or a systemic disease.
• Prescription drug management with risk: the medication decision is independent of the procedure.

Defensible notes split E/M work and procedure work into labeled sections

The single strongest audit defense is structural. An auditor should be able to delete the procedure note entirely and still find a complete, medically necessary E/M service in what remains. Use two clearly headed sections in the same encounter document.

The E/M section should contain:

• A problem-oriented chief complaint: list every problem addressed, not only the procedure indication.
• Medically appropriate history and exam: under 2021 E/M rules these do not set the level, but they substantiate it.
• An assessment for each problem: each problem gets its own status, its own ICD-10-CM code, and its own plan.
• Data reviewed or ordered: name the specific labs, imaging, or external notes.
• Management decisions with risk: include prescriptions, referrals, and diagnostic escalation.

The procedure section should contain:

• Indication and pre-procedure assessment: keep this work here, where it is paid.
• Informed consent, site, and laterality: document these elements in the procedure note only.
• Technique, agents, and lot numbers: record drug, dose, and units where applicable.
• Complications and post-procedure instructions: this work is also part of the global payment.

Do not count procedure work toward the E/M level. Under the 2021 MDM risk table, "decision regarding minor surgery with identified patient or procedure risk factors" is moderate risk. Many MACs and commercial auditors treat that decision as bundled into the minor procedure. The conservative approach is to never rely on the procedure decision to elevate the separate E/M.

Time-based leveling has the same boundary. CPT excludes time spent on separately reported services from E/M total time. If you level by time, document only the minutes spent on the separate evaluation and management. State that procedure time, consent, and post-procedure care were excluded.

MDM thresholds determine the E/M level on procedure days

Use this table as a point-of-care reference. MDM levels follow the 2021 AMA framework, where two of three elements (problems, data, risk) must be met.

Knee osteoarthritis injections need a separate problem or a changed plan

Consider an established patient with M17.11 (ICD-10-CM), unilateral primary osteoarthritis of the right knee, who returns for a scheduled corticosteroid injection. If the knee is unchanged and the plan is the injection, the claim is 20610 plus the drug code (for example, J1030 for methylprednisolone acetate 40 mg). No E/M is reported.

The visit changes when the physician also documents CKD stage 3 progression on recent labs. The physician discontinues the patient's chronic meloxicam and prescribes topical diclofenac instead. That work is prescription drug management for a chronic illness affecting a second organ system. It is separately identifiable and supports 99214-25, with N18.3x linked to the E/M line and M17.11 linked to both.

A frequent documentation failure is a single blended paragraph stating "knee pain worse, discussed options, injection performed." That sentence describes the procedure indication, not separate work. Auditors deny these claims at high rates because the note cannot be split.

Actinic keratosis destruction rarely supports an E/M on its own

For a patient with known L57.0 (ICD-10-CM), actinic keratosis, the lesion examination and treatment discussion belong to CPT 17000 and 17003. Because 17000 carries a 10-day global, follow-up for those treated lesions within 10 days is also included.

Separate E/M work in dermatology usually involves a distinct problem. Examples include a changing pigmented lesion requiring a dermoscopic evaluation and a documented biopsy decision, or a new inflammatory dermatosis requiring prescription therapy. A total body skin examination performed only because the patient presented for AK treatment does not, by itself, establish a separate service.

Dermatology faces heightened modifier 25 scrutiny. The specialty consistently appears among the highest users of the modifier in CMS and OIG utilization data. Expect commercial payers to request records on a sample of 99212 to 99215 claims billed with minor procedures.

G2211 is not payable with modifier 25 on procedure days

CMS created HCPCS G2211 for the inherent complexity of longitudinal care relationships. In CY 2025, CMS allowed G2211 when the office E/M carries modifier 25 only if the same-day service is an annual wellness visit, vaccine administration, or a Medicare Part B preventive service. That boundary continues under the CY 2026 PFS.

When the modifier 25 E/M accompanies a minor procedure such as 20610, 11102, or 17000, G2211 is not payable. Appending it generates a denial and an avoidable audit flag. Configure claim scrubbers to block the G2211 plus procedure plus modifier 25 combination automatically.

The revenue opportunity lives elsewhere. Specialists who serve as the continuing focal point for a serious or complex condition (rheumatoid arthritis, psoriasis on biologics, progressive osteoarthritis) can capture G2211 on non-procedure follow-ups. At a national rate of roughly $16 per claim, a practice recovering $15,600+ annually is capturing about 975 eligible longitudinal visits, or roughly 20 per week. See CPT G2211 Complexity Capture Architecture for qualifying documentation language.

Five documentation patterns trigger most modifier 25 audits

The HHS Office of Inspector General found that 35% of claims using modifier 25 did not meet program requirements in its landmark review (OEI-07-03-00470). Payer algorithms still target the same patterns:

• Modifier 25 on nearly every procedure claim: high attachment rates relative to specialty peers draw prepayment review.
• Identical diagnosis codes on both lines: this pattern is legal, but it shifts the full burden to the narrative.
• Cloned or templated E/M text: identical assessments across visits suggest no individualized work.
• 99211 with modifier 25 by physicians: this pairing is rarely supportable and frequently flagged.
• Time-based levels including procedure minutes: auditors recalculate time and downcode or deny.

Commercial payers may apply stricter rules than Medicare, including payment reductions or mandatory record submission for modifier 25 claims. Check each major contract annually, because these policies change outside the PFS cycle.

AI-drafted notes must remain physician-attested under state law

Ambient AI documentation can reduce modifier 25 denials when it is structured correctly. The scribe should produce a problem-oriented E/M assessment and a discrete procedure note, with each problem mapped to its own ICD-10-CM code. It should never auto-generate an E/M level from procedure content.

State law governs the deployment. Several states regulate patient disclosure for AI-assisted communication and recording consent. California SB 1120 requires that medical necessity determinations in utilization review rest on a licensed clinician's judgment, not an algorithm alone. Review the State AI Scribe Rules & Statutory Compliance Hub before rollout in each state where you practice.

Integration architecture also affects compliance. A browser overlay that writes into the existing EHR note preserves the physician's signature workflow and the native audit trail. The EHR Browser Overlay Architecture guide compares that approach with direct API integration.

Merry AI Pro costs 1.3% of one medical assistant

A fully loaded medical assistant costs approximately $48,000 per year once wages, benefits, payroll taxes, and training are included. Merry AI Pro costs $54 per month on annual billing, or $648 per year. That is 1.3% of the MA labor denominator, for structured E/M and procedure documentation on every encounter.

The return depends on clinical documentation quality, not volume. A single defensible 99214-25 recovered per week often exceeds the annual subscription cost. Combine that with correctly targeted G2211 capture, and the documentation layer pays for itself within the first quarter.

Frequently asked questions about Modifier 25 documentation for same-day E/M with minor procedures

Does modifier 25 require a different diagnosis than the procedure?

No. CPT and CMS both state that a different diagnosis is not required. The note must instead show E/M work beyond the usual pre-procedure assessment, such as evaluating a new problem, managing a worsening chronic condition, or prescription management that the procedure payment does not already cover.

Can I bill G2211 with a modifier 25 E/M on a procedure day?

No. Under the CY 2026 PFS, G2211 remains payable with modifier 25 only when the same-day service is an annual wellness visit, vaccine administration, or a Medicare Part B preventive service. When the modifier 25 E/M accompanies a minor procedure such as 20610 or 17000, G2211 is denied.

Does a new patient visit automatically support modifier 25?

No. NCCI policy states that new patient status alone does not justify a separate E/M on the day of a minor procedure. The documentation must still show significant evaluation beyond deciding to perform the procedure, such as working up an undiagnosed complaint or addressing additional problems.

Can procedure time count toward a time-based E/M level?

No. CPT excludes time spent performing separately reported services from E/M total time. If you select the E/M level by time, document minutes spent only on the separate evaluation and management work, and state explicitly that procedure time, consent, and post-procedure care were excluded.

How does an AI scribe help defend modifier 25 claims?

An AI scribe like Merry AI can draft the E/M assessment and the procedure note as separate, labeled sections, linking each problem to its own diagnosis code. The physician must still review, edit, and attest the note, because payers audit clinical judgment, not software output.